This review found that endoscopic haemoclips are superior to injection therapy but comparable to thermocoagulation in patients with gastrointestinal bleeding. The review was generally well conducted and the authors' conclusions appear justified.
Two reviewers independently extracted the data into a standard data extraction form and a third reviewer resolved any disagreements. Data on the numbers of events in each group were used to calculate the relative risk (RR) and 95% confidence intervals (CIs) for each study.
Methods of synthesis
How were the studies combined? The studies were pooled by meta-analysis, using the Mantel-Haenszel fixed-effect model where there was no evidence of heterogeneity and a random-effects model where statistically significant heterogeneity was observed. Publication bias was not assessed.
How were differences between studies investigated? Statistical heterogeneity was assessed using the chi-squared test (p<0.1) and the I-squared test (high values show increasing heterogeneity). Subgroup analyses were conducted for the different comparisons included. One-way sensitivity analyses were conducted on study duration, adjuvant proton-pump inhibitors and study quality.
Results of the review
Fifteen RCTs (n=1,156) were included in the review. Two studies were included in abstract form and were preliminary results from RCTs; the other 13 studies were completed RCTs.
Of the 15 included trials, four were graded below 3 out of 5 for quality.
Haemoclips versus injections (8 RCTs).
There were no significant differences between groups in initial haemostasis (RR 1.01, 95% CI: 0.96, 1.06) or all-cause mortality (RR 1.45, 95% CI: 0.44, 4.74). Haemoclips showed a significant reduction in re-bleeding (RR 0.49, 95% CI: 0.30, 0.79) and the need for surgery (RR 0.37, 95% CI: 0.15, 0.9), and a marginally higher probability in achieving definitive haemostasis (RR 1.14, 95% CI: 1.00, 1.30). Statistical heterogeneity was observed for the outcome of definitive haemostasis (I-squared 6.6%; p=0.07).
Haemoclips plus injections versus injections (7 RCTs).
There were no significant differences between groups in initial haemostasis (RR 1.00, 95% CI: 0.95, 1.05) or all-cause mortality (RR 1.23, 95% CI: 0.45, 3.37). Haemoclips showed significantly higher success in definitive haemostasis (RR 1.13, 95% CI: 1.03, 1.23) compared with injection alone and also showed a significant reduction in re-bleeding (RR 0.47, 95% CI: 0.28, 0.76) and the need for surgery (RR 0.23, 95% CI: 0.08, 0.70). There was no evidence of statistical heterogeneity for any outcome (p<0.1) Haemoclips versus thermocoagulation with or without injection (4 RCTs). There were no significant differences for any outcome: initial haemostasis (RR 0.94, 95% CI: 0.84, 1.07), definitive haemostasis (RR 1.00, 95% CI: 0.77, 1.31), re-bleeding (RR 0.65, 95% CI: 0.21, 2.02), need for surgery (RR 0.84, 95% CI: 0.32, 2.24) or all-cause mortality (RR 0.96, 95% CI: 0.34, 2.76). Statistical heterogeneity was observed for initial and definitive haemostasis (I-squared 75.5% and p=0.006; I-squared 84.0% and p<0.01) and re-bleeding (I-squared 53.3%; p=0.09).
Sensitivity analyses showed the results for initial and definitive haemostasis, re-bleeding and the need for surgery to be consistent for study duration, the use of proton-pump inhibitors and study quality.
Some data on clip failure were also reported.
Authors' conclusions
Endoscopic clipping is superior to endoscopic injection and comparable to thermocoagulation in securing haemostasis of bleeding peptic ulcers and Dieulafoy lesions.
